Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07849803) titled 'Effect of Acoltremon Ophthalmic Solution 0.003% on Tear Production and Symptoms in Patients With Tear Deficiency and Concurrent Neuropathic Corneal Pain' on Sept. 24.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: University of South Florida
Condition:
Ocular Pain
Dry Eye
Intervention:
Drug: acoltremon ophthalmic solution 0.003%...
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: October 2026
Target Sample Size: 28
Countries of Recruitment:
United St...